ArticleResearch and reports in urology2024

Relugolix Plus Enzalutamide For Metastatic Hormone-Sensitive Prostate Cancer: A Case Report.

Alastair Thomson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.